Host-cell positive transcription elongation factor b kinase activity is essential and limiting for HIV type 1 replication

O Flores, G Lee, J Kessler, M Miller… - Proceedings of the …, 1999 - National Acad Sciences
O Flores, G Lee, J Kessler, M Miller, W Schlief, J Tomassini, D Hazuda
Proceedings of the National Academy of Sciences, 1999National Acad Sciences
HIV-1 gene expression and viral replication require the viral transactivator protein Tat. The
RNA polymerase II transcriptional elongation factor P-TEFb (cyclin-dependent kinase
9/cyclin T) is a cellular protein kinase that has recently been shown to be a key component
of the Tat-transactivation process. For this report, we studied the requirement for P-TEFb in
HIV-1 infection, and we now show that P-TEFb is both essential and limiting for HIV-1
replication. Attenuation of P-TEFb kinase activity either by expression of a dominant …
HIV-1 gene expression and viral replication require the viral transactivator protein Tat. The RNA polymerase II transcriptional elongation factor P-TEFb (cyclin-dependent kinase 9/cyclin T) is a cellular protein kinase that has recently been shown to be a key component of the Tat-transactivation process. For this report, we studied the requirement for P-TEFb in HIV-1 infection, and we now show that P-TEFb is both essential and limiting for HIV-1 replication. Attenuation of P-TEFb kinase activity either by expression of a dominant-negative cyclin-dependent kinase 9 transgene or through the use of small-molecule inhibitors suppresses HIV-1 gene expression and HIV-1 replication. Inhibition of HIV-1 replication is affected in a manner consistent with a direct and specific effect on P-TEFb and the known functional role of P-TEFb in Tat-activated transcription. Tat-activated expression of HIV-1 genes seems uniquely dependent on P-TEFb, as inhibition of P-TEFb activity and HIV-1 replication can be achieved without compromising cell viability or RNA polymerase II-dependent cellular gene transcription. Selective inhibition of the P-TEFb kinase may therefore provide a novel approach for developing chemotherapeutic agents against HIV-1.
National Acad Sciences